| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.18 | 0.0004 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.32 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.005 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.005 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.01 |